Interventions: Patients entered a 4-week, open run-in period, receiving fluticasone propionate 50µg twice daily via a Diskus™ inhalation device. Patients whose asthma was well controlled ...

Fluticasone is a prescription corticosteroid for long-term treatment of respiratory disorders, such as asthma and COPD. It is not supposed to relieve sudden breathing problems, so it won’t replace a ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide ... twice daily from a Diskus™ inhaler for a 4-week run-in period ...

Seretide (salmeterol xinafoate/fluticasone propionate ... Seretide is available both as a pMDI and in the Diskus dry powder inhaler, and is also approved for patients with chronic obstructive ...

Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and ...

Teva will make two inhaler products available through this program: generic versions of the AirDuo®RespiClick® (fluticasone propionate/salmeterol xinafoate maintenance inhaler) and ProAir® HFA ...

Teva will make two inhaler products available through this program: generic versions of the AirDuo®RespiClick® (fluticasone propionate/salmeterol xinafoate maintenance inhaler) and ProAir® HFA ...

Despite these benefits, inhalation drug delivery systems are still in the developmental stage, particularly for targeted local delivery. Dry powder inhalers (DPIs) have emerged as a popular choice due ...

ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and ...